Effects of bilateral sequential theta-burst stimulation on 5-HT
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
01 02 2023
01 02 2023
Historique:
received:
28
04
2022
accepted:
12
01
2023
revised:
09
01
2023
entrez:
1
2
2023
pubmed:
2
2
2023
medline:
4
2
2023
Statut:
epublish
Résumé
Theta-burst stimulation (TBS) represents a brain stimulation technique effective for treatment-resistant depression (TRD) as underlined by meta-analyses. While the methodology undergoes constant refinement, bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) appears promising to restore left DLPFC hypoactivity and right hyperactivity found in depression. The post-synaptic inhibitory serotonin-1A (5-HT
Identifiants
pubmed: 36725835
doi: 10.1038/s41398-023-02319-3
pii: 10.1038/s41398-023-02319-3
pmc: PMC9892572
doi:
Substances chimiques
Receptor, Serotonin, 5-HT1A
112692-38-3
Serotonin
333DO1RDJY
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Subventions
Organisme : Austrian Science Fund FWF
ID : DOC 33
Pays : Austria
Informations de copyright
© 2023. The Author(s).
Références
Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21:10.
doi: 10.1007/s11920-019-0997-0
Smith K. Trillion-dollar brain drain. Nature. 2011;478:15.
doi: 10.1038/478015a
Bartova L, Dold M, Kautzky A, Fabbri C, Spies M, Serretti A, et al. Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice. World J Biol Psychiatry. 2019;20:427–48.
doi: 10.1080/15622975.2019.1635270
Dold M, Kasper S. Evidence-based pharmacotherapy of treatment-resistant unipolar depression. Int J Psychiatry Clin Pract. 2017;21:13–23.
doi: 10.1080/13651501.2016.1248852
Kraus C, Kadriu B, Lanzenberger R, Zarate CA Jr, Kasper S. Prognosis and improved outcomes in major depression: a review. Transl Psychiatry. 2019;9:127.
doi: 10.1038/s41398-019-0460-3
Kasper S, Cubała WJ, Fagiolini A, Ramos-Quiroga JA, Souery D, Young AH. Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance. World J Biol Psychiatry. 2021;22:468–82.
doi: 10.1080/15622975.2020.1836399
Blumberger DM, Mulsant BH, Daskalakis ZJ. What is the role of brain stimulation therapies in the treatment of depression? Curr Psychiatry Rep. 2013;15:368.
doi: 10.1007/s11920-013-0368-1
Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet. 2018;391:1683–92.
doi: 10.1016/S0140-6736(18)30295-2
Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005;45:201–6.
doi: 10.1016/j.neuron.2004.12.033
Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clin Neurophysiol. 2020;131:474–528.
doi: 10.1016/j.clinph.2019.11.002
Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychological Med. 2014;44:225–39.
doi: 10.1017/S0033291713000512
O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–16.
doi: 10.1016/j.biopsych.2007.01.018
George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67:507–16.
doi: 10.1001/archgenpsychiatry.2010.46
Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–7.
doi: 10.1016/S0140-6736(85)92413-4
Höflich G, Kasper S, Hufnagel A, Ruhrmann S, Möller H-J. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression—a report of two cases. Hum Psychopharmacol. 1993;8:361–5.
doi: 10.1002/hup.470080510
Casula EP, Tarantino V, Basso D, Arcara G, Marino G, Toffolo GM, et al. Low-frequency rTMS inhibitory effects in the primary motor cortex: Insights from TMS-evoked potentials. NeuroImage. 2014;98:225–32.
doi: 10.1016/j.neuroimage.2014.04.065
Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125:2150–206.
doi: 10.1016/j.clinph.2014.05.021
Li H, Cui L, Li J, Liu Y, Chen Y. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials. J Affect Disord. 2021;287:115–24.
doi: 10.1016/j.jad.2021.03.019
Berlim MT, McGirr A, Rodrigues Dos Santos N, Tremblay S, Martins R. Efficacy of theta burst stimulation (TBS) for major depression: an exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res. 2017;90:102–9.
doi: 10.1016/j.jpsychires.2017.02.015
Lazzaro VD, Ziemann U, Lemon RN. State of the art: physiology of transcranial motor cortex stimulation. Brain Stimulation. 2008;1:345–62.
doi: 10.1016/j.brs.2008.07.004
Ilić TV, Ziemann U. Exploring motor cortical plasticity using transcranial magnetic stimulation in humans. Ann N Y Acad Sci. 2005;1048:175–84.
doi: 10.1196/annals.1342.016
Ziemann U, Ilić TV, Jung P. Long-term potentiation (LTP)-like plasticity and learning in human motor cortex-investigations with transcranial magnetic stimulation (TMS). Suppl Clin Neurophysiol. 2006;59:19–25.
doi: 10.1016/S1567-424X(09)70007-8
Reithler J, Peters JC, Sack AT. Multimodal transcranial magnetic stimulation: using concurrent neuroimaging to reveal the neural network dynamics of noninvasive brain stimulation. Prog Neurobiol. 2011;94:149–65.
doi: 10.1016/j.pneurobio.2011.04.004
Garnaat SL, Fukuda AM, Yuan S, Carpenter LL. Identification of clinical features and biomarkers that may inform a personalized approach to rTMS for depression. Personalized Med Psychiatry. 2019;17–18:4–16.
doi: 10.1016/j.pmip.2019.09.001
Hernández-Ribas R, Deus J, Pujol J, Segalàs C, Vallejo J, Menchón JM, et al. Identifying brain imaging correlates of clinical response to repetitive transcranial magnetic stimulation (rTMS) in major depression. Brain Stimul. 2013;6:54–61.
doi: 10.1016/j.brs.2012.01.001
Fidalgo TM, Morales-Quezada JL, Muzy GS, Chiavetta NM, Mendonca ME, Santana MV, et al. Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review. J ECT. 2014;30:47–61.
doi: 10.1097/YCT.0b013e31828b34d8
Stöhrmann P, Godbersen GM, Reed MB, Unterholzner J, Klöbl M, Baldinger-Melich P, et al. Effects of bilateral sequential theta-burst stimulation on functional connectivity in treatment-resistant depression: first results. J Affect. Disord. 2023;324:660–669.
Paus T, Castro-Alamancos MA, Petrides M. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci. 2001;14:1405–11.
doi: 10.1046/j.0953-816x.2001.01757.x
Knoch D, Treyer V, Regard M, Müri RM, Buck A, Weber B. Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. NeuroImage. 2006;31:641–8.
doi: 10.1016/j.neuroimage.2005.12.025
Speer AM, Willis MW, Herscovitch P, Daube-Witherspoon M, Shelton JR, Benson BE, et al. Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: II. Effects of prefrontal cortex rTMS. Biol Psychiatry. 2003;54:826–32.
doi: 10.1016/S0006-3223(03)00324-X
Ferrarelli F, Haraldsson HM, Barnhart TE, Roberts AD, Oakes TR, Massimini M, et al. A [17F]-fluoromethane PET/TMS study of effective connectivity. Brain Res Bull. 2004;64:103–13.
doi: 10.1016/j.brainresbull.2004.04.020
Kimbrell TA, Dunn RT, George MS, Danielson AL, Willis MW, Repella JD, et al. Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers. Psychiatry Res. 2002;115:101–13.
doi: 10.1016/S0925-4927(02)00041-0
Ko JH, Monchi O, Ptito A, Bloomfield P, Houle S, Strafella AP. Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study. Eur J Neurosci. 2008;28:2147–55.
doi: 10.1111/j.1460-9568.2008.06501.x
Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain. 2003;126(Pt 12):2609–15.
doi: 10.1093/brain/awg268
Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21:Rc157.
doi: 10.1523/JNEUROSCI.21-15-j0003.2001
Sibon I, Strafella AP, Gravel P, Ko JH, Booij L, Soucy JP, et al. Acute prefrontal cortex TMS in healthy volunteers: effects on brain 11C-alphaMtrp trapping. NeuroImage. 2007;34:1658–64.
doi: 10.1016/j.neuroimage.2006.08.059
Lu R, Zhang C, Liu Y, Wang L, Chen X, Zhou X. The effect of bilateral low-frequency rTMS over dorsolateral prefrontal cortex on serum brain-derived neurotropic factor and serotonin in patients with generalized anxiety disorder. Neurosci Lett. 2018;684:67–71.
doi: 10.1016/j.neulet.2018.07.008
Ben-Shachar D, Belmaker RH, Grisaru N, Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm. 1997;104:191–7.
doi: 10.1007/BF01273180
Kole MH, Fuchs E, Ziemann U, Paulus W, Ebert U. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res. 1999;826:309–12.
doi: 10.1016/S0006-8993(99)01257-3
Pollandt S, Drephal C, Albrecht D. 8-OH-DPAT suppresses the induction of LTP in brain slices of the rat lateral amygdala. Neuroreport. 2003;14:895–7.
doi: 10.1097/00001756-200305060-00025
Gur E, Lerer B, Dremencov E, Newman ME. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport. 2000;11:2925–9.
doi: 10.1097/00001756-200009110-00019
Johnson MT, McCullough J, Nindl G, Chamberlain JK. Autoradiographic evaluation of electromagnetic field effects on serotonin (5HT1A) receptors in rat brain. Biomed Sci Instrum. 2003;39:466–70.
Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, et al. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry. 2007;61:1081–9.
doi: 10.1016/j.biopsych.2006.05.022
Nugent AC, Bain EE, Carlson PJ, Neumeister A, Bonne O, Carson RE, et al. Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression. Eur Neuropsychopharmacol. 2013;23:822–9.
doi: 10.1016/j.euroneuro.2012.11.005
Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004;24:589–91.
doi: 10.1523/JNEUROSCI.4921-03.2004
Savitz J, Lucki I, Drevets WC. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol. 2009;88:17–31.
doi: 10.1016/j.pneurobio.2009.01.009
Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, et al. Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression. Mol Psychiatry. 2013;18:1.
doi: 10.1038/mp.2012.177
Spindelegger C, Lanzenberger R, Wadsak W, Mien LK, Stein P, Mitterhauser M, et al. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Mol Psychiatry. 2009;14:1040–50.
doi: 10.1038/mp.2008.35
Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, et al. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry. 2013;18:93–100.
doi: 10.1038/mp.2012.93
Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, et al. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging. Int J Neuropsychopharmacol. 2014;18:pyu063.
doi: 10.1093/ijnp/pyu063
Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Screening questionnaire before TMS: an update. Clin Neurophysiol. 2011;122:1686.
doi: 10.1016/j.clinph.2010.12.037
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
doi: 10.1016/j.jbi.2019.103208
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.
doi: 10.1016/j.jbi.2008.08.010
Ge R, Blumberger DM, Downar J, Daskalakis ZJ, Dipinto AA, Tham JCW, et al. Abnormal functional connectivity within resting-state networks is related to rTMS-based therapy effects of treatment resistant depression: a pilot study. J Affect Disord. 2017;218:75–81.
doi: 10.1016/j.jad.2017.04.060
Li CT, Chen MH, Juan CH, Huang HH, Chen LF, Hsieh JC, et al. Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study. Brain. 2014;137(Pt 7):2088–98.
doi: 10.1093/brain/awu109
Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry. 2012;72:595–603.
doi: 10.1016/j.biopsych.2012.04.028
Hahn A, Nics L, Baldinger P, Ungersböck J, Dolliner P, Frey R. et al. Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling. NeuroImage. 2012;62:199–206.
Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien L-K, et al. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry. 2007;61:1081–9.
doi: 10.1016/j.biopsych.2006.05.022
Wadsak W, Mien L-K, Ettlinger DE, Eidherr H, Haeusler D, Sindelar K-M, et al. 18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers. Nucl Med Biol. 2007;34:1019–28.
doi: 10.1016/j.nucmedbio.2007.06.012
Savli M, Bauer A, Mitterhauser M, Ding Y-S, Hahn A, Kroll T, et al. Normative database of the serotonergic system in healthy subjects using multi-tracer PET. NeuroImage. 2012;63:447–59.
doi: 10.1016/j.neuroimage.2012.07.001
Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533–9.
doi: 10.1038/sj.jcbfm.9600493
Parsey RV, Slifstein M, Hwang D-R, Abi-Dargham A, Simpson N, Mawlawi O. et al. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab. 2000;20:1111–33.
Fink M, Wadsak W, Savli M, Stein P, Moser U, Hahn A, et al. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. NeuroImage. 2009;45:598–605.
doi: 10.1016/j.neuroimage.2008.11.033
Gray NA, Milak MS, DeLorenzo C, Ogden RT, Huang YY, Mann JJ, et al. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biol Psychiatry. 2013;74:26–31.
doi: 10.1016/j.biopsych.2012.11.012
Parsey RV, Ogden RT, Miller JM, Tin A, Hesselgrave N, Goldstein E, et al. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry. 2010;68:170–8.
doi: 10.1016/j.biopsych.2010.03.023
Hahn A, Nics L, Baldinger P, Wadsak W, Savli M, Kraus C.et al. Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635. Nucl Med Biol. 2013;40:371–7.
Garcia-Garcia AL, Newman-Tancredi A, Leonardo ED. 5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology. 2014;231:623–36.
doi: 10.1007/s00213-013-3389-x
Aberra AS, Wang B, Grill WM, Peterchev AV. Simulation of transcranial magnetic stimulation in head model with morphologically-realistic cortical neurons. Brain Stimul. 2020;13:175–89.
doi: 10.1016/j.brs.2019.10.002
Keck ME, Sillaber I, Ebner K, Welt T, Toschi N, Kaehler ST, et al. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci. 2000;12:3713–20.
doi: 10.1046/j.1460-9568.2000.00243.x
Kanno M, Matsumoto M, Togashi H, Yoshioka M, Mano Y. Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum. J neurological Sci. 2004;217:73–81.
doi: 10.1016/j.jns.2003.08.013
Juckel G, Mendlin A, Jacobs BL. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology. 1999;21:391–8.
doi: 10.1016/S0893-133X(98)00097-9
Löffler S, Gasca F, Richter L, Leipscher U, Trillenberg P, Moser A. The effect of repetitive transcranial magnetic stimulation on monoamine outflow in the nucleus accumbens shell in freely moving rats. Neuropharmacology. 2012;63:898–904.
doi: 10.1016/j.neuropharm.2012.06.045
Ben-Shachar D, Gazawi H, Riboyad-Levin J, Klein E. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res. 1999;816:78–83.
doi: 10.1016/S0006-8993(98)01119-6
Baeken C, De Raedt R, Bossuyt A, Van Hove C, Mertens J, Dobbeleir A, et al. The impact of HF-rTMS treatment on serotonin(2A) receptors in unipolar melancholic depression. Brain Stimul. 2011;4:104–11.
doi: 10.1016/j.brs.2010.09.002
Malaguti A, Rossini D, Lucca A, Magri L, Lorenzi C, Pirovano A, et al. Role of COMT, 5-HT(1A), and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation. Depression anxiety. 2011;28:568–73.
doi: 10.1002/da.20815
Zanardi R, Magri L, Rossini D, Malaguti A, Giordani S, Lorenzi C, et al. Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression. Eur Neuropsychopharmacol. 2007;17:651–7.
doi: 10.1016/j.euroneuro.2007.03.008
Xu Y, Kappen M, Peremans K, De Bundel D, Van Eeckhaut A, Van Laeken N, et al. Accelerated HF-rTMS Modifies SERT Availability in the Subgenual Anterior Cingulate Cortex: A Canine [11C]DASB Study on the Serotonergic System. J Clin Med. 2022;11:1531.
doi: 10.3390/jcm11061531
Liston C, Chen AC, Zebley BD, Drysdale AT, Gordon R, Leuchter B, et al. Default mode network mechanisms of transcranial magnetic stimulation in depression. Biol psychiatry. 2014;76:517–26.
doi: 10.1016/j.biopsych.2014.01.023
Vogt BA, Pandya DN. Cingulate cortex of the rhesus monkey: II. Cortical afferents. J Comp Neurol. 1987;262:271–89.
doi: 10.1002/cne.902620208
Hoogendam JM, Ramakers GM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 2010;3:95–118.
doi: 10.1016/j.brs.2009.10.005
Huang YZ, Rothwell JC, Chen RS, Lu CS, Chuang WL. The theoretical model of theta burst form of repetitive transcranial magnetic stimulation. Clin Neurophysiol. 2011;122:1011–8.
doi: 10.1016/j.clinph.2010.08.016
Cambiaghi M, Cherchi L, Masin L, Infortuna C, Briski N, Caviasco C, et al. High-frequency repetitive transcranial magnetic stimulation enhances layer II/III morphological dendritic plasticity in mouse primary motor cortex. Behav Brain Res. 2021;410:113352.
doi: 10.1016/j.bbr.2021.113352
Zanderigo F, Pantazatos S, Rubin-Falcone H, Ogden RT, Chhetry BT, Sullivan G, et al. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder. Brain Struct Funct. 2018;223:2609–25.
doi: 10.1007/s00429-018-1649-6
Kraus C, Hahn A, Savli M, Kranz GS, Baldinger P, Höflich A, et al. Serotonin-1A receptor binding is positively associated with gray matter volume - a multimodal neuroimaging study combining PET and structural MRI. NeuroImage. 2012;63:1091–8.
doi: 10.1016/j.neuroimage.2012.07.035
Burnet PW, Eastwood SL, Harrison PJ. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int. 1997;30:565–74.
doi: 10.1016/S0197-0186(96)00124-6
Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology. 1996;14:35–46.
doi: 10.1016/S0893-133X(96)80057-1
Clarke D, Beros J, Bates KA, Harvey AR, Tang AD, Rodger J. Low intensity repetitive magnetic stimulation reduces expression of genes related to inflammation and calcium signalling in cultured mouse cortical astrocytes. Brain Stimul. 2021;14:183–91.
doi: 10.1016/j.brs.2020.12.007
Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry. 1990;147:1313–7.
doi: 10.1176/ajp.147.10.1313
Aleman A. Use of repetitive transcranial magnetic stimulation for treatment in psychiatry. Clin Psychopharmacol Neurosci. 2013;11:53–9.
doi: 10.9758/cpn.2013.11.2.53
Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39:65–75.
doi: 10.1017/S0033291708003462
Li CT, Chen MH, Juan CH, Liu RS, Lin WC, Bai YM, et al. Effects of prefrontal theta-burst stimulation on brain function in treatment-resistant depression: A randomized sham-controlled neuroimaging study. Brain Stimul. 2018;11:1054–62.
doi: 10.1016/j.brs.2018.04.014
Plewnia C, Pasqualetti P, Große S, Schlipf S, Wasserka B, Zwissler B, et al. Treatment of major depression with bilateral theta burst stimulation: a randomized controlled pilot trial. J Affect Disord. 2014;156:219–23.
doi: 10.1016/j.jad.2013.12.025
Voigt JD, Leuchter AF, Carpenter LL. Theta burst stimulation for the acute treatment of major depressive disorder: a systematic review and meta-analysis. Transl Psychiatry. 2021;11:330.
doi: 10.1038/s41398-021-01441-4
Lepping P, Schönfeldt-Lecuona C, Sambhi RS, Lanka SV, Lane S, Whittington R, et al. A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation. Acta Psychiatr Scand. 2014;130:326–41.
doi: 10.1111/acps.12276
Kaster TS, Downar J, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, et al. Trajectories of response to dorsolateral prefrontal rTMS in major depression: a THREE-D study. The. Am J Psychiatry. 2019;176:367–75.
doi: 10.1176/appi.ajp.2018.18091096
Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ. 2019;364:l1079.
doi: 10.1136/bmj.l1079
Eisenegger C, Treyer V, Fehr E, Knoch D. Time-course of “off-line” prefrontal rTMS effects-a PET study. NeuroImage. 2008;42:379–84.
doi: 10.1016/j.neuroimage.2008.04.172
Gryglewski G, Lanzenberger R, Kranz GS, Cumming P. Meta-analysis of molecular imaging of serotonin transporters in major depression. J Cereb Blood Flow Metab. 2014;34:1096–103.
doi: 10.1038/jcbfm.2014.82
Moses-Kolko EL, Price JC, Thase ME, Meltzer CC, Kupfer DJ, Mathis CA, et al. Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse. 2007;61:523–30.
doi: 10.1002/syn.20398
Choi YK, Gardner MP, Tarazi FI. Developmental effects of antipsychotic drugs on serotonin receptor subtypes. Synapse. 2017;71:e21988.
doi: 10.1002/syn.21988
Haddjeri N, Blier P, de Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci. 1998;18:10150–6.
doi: 10.1523/JNEUROSCI.18-23-10150.1998
Hensler JG. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci. 2003;72:1665–82.
doi: 10.1016/S0024-3205(02)02482-7